InvestorsHub Logo
Followers 163
Posts 12917
Boards Moderated 1
Alias Born 01/26/2016

Re: SkyLimit2022 post# 516629

Sunday, 09/25/2022 10:26:44 AM

Sunday, September 25, 2022 10:26:44 AM

Post# of 701760
SkyLimit2022,

This trial will determine if DCVax-L given early enough after surgery is enough on it’s own with Poly ICLC vs with the combo. That’s a huge question mark for valuation and this makes it a fair comparison because chemo/rad is out of the picture. Bottom line is it’s ALL on the line. The only other question is whether or not unmethylated will benefit from earlier treatment or the combo as up to 50% might be cured from L plus Poly ICLC alone. “Go big or go home”!; ). Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News